Does competition stimulate drug utilization? The impact of changes in market structure on US drug prices, marketing and utilization-Reference-Cited by-同舟云学术

Does competition stimulate drug utilization? The impact of changes in market structure on US drug prices, marketing and utilization

Published:2012-03 Issue:1 Volume:32 Page:95-109
ISSN:0144-8188
Container-title:International Review of Law and Economics
language:en
Short-container-title:International Review of Law and Economics

Author:

Duflos Gautier,Lichtenberg Frank R.

Publisher

Elsevier BV

Subject

Law,Economics and Econometrics,Finance

Reference32 articles.

1. Berenson, A. (2006). Merck Loses Protection for Patent on Zocor. New York Times, June 23,

2. Berndt, E. R., Kyle, M., & Ling, D. (2003). The Long Shadow of Patent Expiration. Generic Entry and Rx-to-OTC Switches (pp. 229–274), in Scanner Data and Price Indexes, National Bureau of Economic Research.

3. Canadian Institute for Health Information, Drug Expenditure in Canada, 1985 to 2007 (Ottawa: CIHI, 2008). http://secure.cihi.ca/cihiweb/dispPage.jsp?cw_page=download_form_e&cw_sku=DRUGEXP8507ENPDF&cw_ctt=1&cw_dform=N.

4. Chartrand, S. (1999). Patents; A Supreme Court decision leaves many innovators disgusted, angry and outraged. New York Times, June 28, http://www.nytimes.com/1999/06/28/business/patents-supreme-court-decision-leaves-many-innovators-disgusted-angry-outraged.html?scp=4&sq=patents%20supreme%20court&st=cse.

5. Ching, A. T. (2004). Some observations in the US prescription drug market after patent expiration during the 80s. Working paper, Rotman School of Management. Available at SSRN: http://ssrn.com/abstract=1492264.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marketing Strategies of Big Pharma and Impact of Generics in Healthcare;Advances in Healthcare Information Systems and Administration;2023-12-11

2. Has pharmaceutical innovation reduced the average cost of U.S. health care episodes?;International Journal of Health Economics and Management;2023-11-08

3. The Impact of Biopharmaceutical Innovation on Disability, Social Security Recipiency, and Use of Medical Care of U.S. Community Residents, 1998–2015;Forum for Health Economics and Policy;2021-06-01

4. Innovation institutions and the opioid crisis†;Journal of Law and the Biosciences;2020-01

5. The unexpected consequences of generic entry;Journal of Health Economics;2019-12